- Home
- VNDA vs QSI Comparison
VNDA vs QSI Comparison
Compare VNDA & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- QSI
- Stock Information
- Founded
- VNDA 2002
- QSI 2013
- Country
- VNDA United States
- QSI United States
- Employees
- VNDA N/A
- QSI N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- VNDA Health Care
- QSI Health Care
- Exchange
- VNDA Nasdaq
- QSI Nasdaq
- Market Cap
- VNDA 261.7M
- QSI 219.8M
- IPO Year
- VNDA 2006
- QSI N/A
- Fundamental
- Price
- VNDA $4.78
- QSI $1.74
- Analyst Decision
- VNDA Strong Buy
- QSI Strong Buy
- Analyst Count
- VNDA 3
- QSI 3
- Target Price
- VNDA $15.33
- QSI $2.38
- AVG Volume (30 Days)
- VNDA 408.4K
- QSI 9.0M
- Earning Date
- VNDA 07-30-2025
- QSI 08-06-2025
- Dividend Yield
- VNDA N/A
- QSI N/A
- EPS Growth
- VNDA N/A
- QSI N/A
- EPS
- VNDA N/A
- QSI N/A
- Revenue
- VNDA $201,351,000.00
- QSI $3,443,000.00
- Revenue This Year
- VNDA $16.86
- QSI $77.57
- Revenue Next Year
- VNDA $39.78
- QSI $251.34
- P/E Ratio
- VNDA N/A
- QSI N/A
- Revenue Growth
- VNDA 13.37
- QSI 167.94
- 52 Week Low
- VNDA $3.81
- QSI $0.61
- 52 Week High
- VNDA $6.37
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- VNDA 53.88
- QSI 50.07
- Support Level
- VNDA $4.85
- QSI $1.74
- Resistance Level
- VNDA $5.12
- QSI $2.18
- Average True Range (ATR)
- VNDA 0.18
- QSI 0.14
- MACD
- VNDA 0.01
- QSI -0.02
- Stochastic Oscillator
- VNDA 54.05
- QSI 41.27
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.